BIOCON:NSE
Biocon Ltd
349,20 INR
arrow_downward
-0,80%(-2,80) 1 d.
16. 10., 15:30:00 GMT+5:30 · INR
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre BIOCON…
Otvoriť
352,60 INR
Vysoká
353,00 INR
Nízka
348,00 INR
Trh. kap.
568,79 mld.
Priem. obj.
2,97 mil.
Objem
1,88 mil.
Dividenda
0,14 %
Štvrťročná dividenda
0,12 INR
Prvý obchodný deň po vyplatení dividendy
3. 7. 2026
Pomer cena/zárobky
103,38
Max. za 52 týž.
447,15 INR
Min. za 52 týž.
337,70 INR
Výnosy na akciu
3,38 INR
Akcie v obehu
600,00 mil.
Počet zamestnancov
16 tis.
Otvoriť
352,60 INR
Vysoká
353,00 INR
Nízka
348,00 INR
Trh. kap.
568,79 mld.
Priem. obj.
2,97 mil.
Objem
1,88 mil.
Dividenda
0,14 %
Štvrťročná dividenda
0,12 INR
Prvý obchodný deň po vyplatení dividendy
3. 7. 2026
Pomer cena/zárobky
103,38
Max. za 52 týž.
447,15 INR
Min. za 52 týž.
337,70 INR
Výnosy na akciu
3,38 INR
Akcie v obehu
600,00 mil.
Počet zamestnancov
16 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
StreetInsider
·
pred 14 minútami
GreenPower converts $2M in debentures to preferred shares for Nasdaq compliance
Yahoo Finance
·
pred 40 minútami
Wall Street’s record breakouts unravel as investors dump recent winners: Chart of the Day
Simply Wall Street
·
pred 50 minútami
Did Genetic Response Data Just Shift Madrigal Pharmaceuticals (MDGL) Investment Narrative?
Seeking Alpha
·
pred 32 minútami
Weekly Indicators: Long Leading Indicators Turn Neutral As AI-Centric Expansion Rolls On
Profil
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, with U.S. headquarters in Bridgewater, New Jersey. Founded by Kiran Mazumdar-Shaw in 1978 as a partner to the Irish brewing enzyme manufacturer Biocon Biochemicals Ltd., the company manufactures generic active pharmaceutical ingredients that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics, and branded drugs such as biosimilar insulins and antibodies for the Indian domestic market. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy, and nephrology products. Some of Biocon's key brands in India include INSUGEN, BASALOG, BIOMAb EGFR, BLISTO, CANMAb, Evertor, TACROGRAF, ALZUMAb and KRABEVA.
Syngene International Limited is a publicly listed subsidiary of Biocon, operating in the contract research and development organization. Wikipedia
Informácie o subjekte Biocon Ltd
Generálny riaditeľShreehas P Tambe
Zamestnanci16,4 tis.
Dátum založenia29. 11. 1978
Hlavné sídloBangalúr, Karnátaka, India
Odvetvie-
Webbiocon.com